A detailed history of Worldquant Millennium Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 578,116 shares of ABBV stock, worth $105 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
578,116
Previous 229,419 151.99%
Holding current value
$105 Million
Previous $39.3 Million 190.14%
% of portfolio
0.84%
Previous 0.36%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $57.1 Million - $69.5 Million
348,697 Added 151.99%
578,116 $114 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $35.5 Million - $41.5 Million
229,419 New
229,419 $39.3 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $7.58 Million - $8.53 Million
-55,060 Reduced 17.86%
253,194 $39.2 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $514,187 - $595,247
3,849 Added 1.26%
308,254 $45.9 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $40.3 Million - $50.2 Million
304,405 New
304,405 $41 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $1.68 Million - $1.91 Million
-15,797 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $1.66 Million - $1.85 Million
15,797 New
15,797 $1.78 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $13.9 Million - $16.4 Million
-162,377 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $3.69 Million - $4.94 Million
-50,330 Reduced 23.66%
162,377 $15.9 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $4.72 Million - $7.15 Million
73,146 Added 52.41%
212,707 $16.2 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $28.1 Million - $35.2 Million
-390,266 Reduced 73.66%
139,561 $12.4 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $16.4 Million - $19.7 Million
260,122 Added 96.45%
529,827 $40.1 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $2.99 Million - $3.82 Million
45,531 Added 20.31%
269,705 $19.6 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $1.77 Million - $2.08 Million
22,965 Added 11.41%
224,174 $18.1 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $2.84 Million - $3.51 Million
-36,512 Reduced 15.36%
201,209 $18.5 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $917,106 - $1.02 Million
10,315 Added 4.54%
237,721 $22.5 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $20.4 Million - $24.2 Million
227,406 New
227,406 $21.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $321B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Worldquant Millennium Advisors LLC Portfolio

Follow Worldquant Millennium Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.